These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19194174)
1. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect. Vatta M; Sinagra G; Brunelli L; Faulkner G J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):149-56. PubMed ID: 19194174 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Duboscq-Bidot L; Xu P; Charron P; Neyroud N; Dilanian G; Millaire A; Bors V; Komajda M; Villard E Cardiovasc Res; 2008 Jan; 77(1):118-25. PubMed ID: 18006477 [TBL] [Abstract][Full Text] [Related]
3. [The expression of dystrophin in human viral myocarditis and dilated cardiomyopathy]. Xu HF; Li YH; Chen Y; Cheng LB Fa Yi Xue Za Zhi; 2006 Feb; 22(1):12-4. PubMed ID: 16524176 [TBL] [Abstract][Full Text] [Related]
4. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. Tsubata S; Bowles KR; Vatta M; Zintz C; Titus J; Muhonen L; Bowles NE; Towbin JA J Clin Invest; 2000 Sep; 106(5):655-62. PubMed ID: 10974018 [TBL] [Abstract][Full Text] [Related]
6. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory cardiomyopathy: there is a specific matrix destruction in the course of the disease. Towbin JA Ernst Schering Res Found Workshop; 2006; (55):219-50. PubMed ID: 16329665 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. Diegoli M; Grasso M; Favalli V; Serio A; Gambarin FI; Klersy C; Pasotti M; Agozzino E; Scelsi L; Ferlini A; Febo O; Piccolo G; Tavazzi L; Narula J; Arbustini E J Am Coll Cardiol; 2011 Aug; 58(9):925-34. PubMed ID: 21851881 [TBL] [Abstract][Full Text] [Related]
9. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Badorff C; Lee GH; Lamphear BJ; Martone ME; Campbell KP; Rhoads RE; Knowlton KU Nat Med; 1999 Mar; 5(3):320-6. PubMed ID: 10086389 [TBL] [Abstract][Full Text] [Related]
10. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Vatta M; Stetson SJ; Perez-Verdia A; Entman ML; Noon GP; Torre-Amione G; Bowles NE; Towbin JA Lancet; 2002 Mar; 359(9310):936-41. PubMed ID: 11918913 [TBL] [Abstract][Full Text] [Related]
11. Genetics of dilated cardiomyopathy. Kärkkäinen S; Peuhkurinen K Ann Med; 2007; 39(2):91-107. PubMed ID: 17453673 [TBL] [Abstract][Full Text] [Related]
12. Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy. Campos EC; O'Connell JL; Malvestio LM; Romano MM; Ramos SG; Celes MR; Prado CM; Simões MV; Rossi MA Eur J Pharmacol; 2011 Nov; 670(2-3):541-53. PubMed ID: 21946105 [TBL] [Abstract][Full Text] [Related]
13. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. Olson TM; Kishimoto NY; Whitby FG; Michels VV J Mol Cell Cardiol; 2001 Apr; 33(4):723-32. PubMed ID: 11273725 [TBL] [Abstract][Full Text] [Related]
14. Different electrophoretic techniques produce conflicting data in the analysis of myocardial samples from dilated cardiomyopathy patients: protein levels do not necessarily reflect mRNA levels. dos Remedios CG; Berry DA; Carter LK; Coumans JV; Heinke MY; Kiessling PC; Seeto RK; Thorvaldson T; Trahair T; Yeoh T; Yao M; Gunning PW; Hardeman E; Humphery-Smith I; Naidoo D; Keogh A Electrophoresis; 1996 Jan; 17(1):235-8. PubMed ID: 8907547 [TBL] [Abstract][Full Text] [Related]
15. Determination of P2X1alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles. Berry DA; Balcar VJ; Barden JA; Keogh A; dos Remedios CG Electrophoresis; 2000 Nov; 21(17):3857-62. PubMed ID: 11271504 [TBL] [Abstract][Full Text] [Related]
16. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Arimura T; Hayashi T; Matsumoto Y; Shibata H; Hiroi S; Nakamura T; Inagaki N; Hinohara K; Takahashi M; Manatsu SI; Sasaoka T; Izumi T; Bonne G; Schwartz K; Kimura A Biochem Biophys Res Commun; 2007 May; 357(1):162-7. PubMed ID: 17416352 [TBL] [Abstract][Full Text] [Related]
18. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Heydemann A; McNally EM Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047 [TBL] [Abstract][Full Text] [Related]
19. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357 [TBL] [Abstract][Full Text] [Related]